A Stanford-led study finds Resero Bio’s uRARE-seq urine cfRNA test detects bladder cancer and predicts therapy response in 683 samples.
– ARO-MAPT utilizes the Targeted RNAi Molecule (TRiM™) platform designed for subcutaneous administration and systemic delivery to the CNS by crossing the blood ...
Get to know researchers from KI and Karolinska CCC and hear about their research, advice, challenges, and hopes for the future of cancer research. Meet Elias Arnér, Hildur Helgadottir, Marco Gerling, ...
Once registered, participants may begin forwarding their questions for the CEO to Tribe Public at research@tribepublic.com or share their questions via the ZOOM chat feature during the event. Tribe ...
Health system leaders face relentless pressure to deliver capital cost savings, eliminate equipment redundancy, and repeatedly defend replacement cycles. Yet they must often confront these challenges ...
This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. This work is licensed under a Creative Commons ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results